TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
RMTI

Rockwell Medical Inc

Healthcare · Drug Manufacturers - Specialty & Generic

8.00$ -2.4% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Balance Sheet

Rockwell Medical Inc (RMTI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 57 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RMTI
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
83 83 80 69 66 59 52 41 38 53 49 57 48 44 67 59 85 78 69 64 59 49 37 59 54 47 40 38 53 52 51 53 57 59 54 53 57 57 57 57
80 79 75 64 61 49 44 36 32 47 40 48 41 37 59 52 78 69 59 52 46 35 25 47 42 35 30 28 28 29 27 30 34 37 33 32 38 38 37 36
19 17 12 8.3 3.9 8.4 3.3 1.7 4.3 23 21 21 14 12 37 27 57 49 36 32 23 13 9.9 31 13 10 11 9.0 7.8 9.0 6.6 12 12 16 11 12 14 11 9.6 11
58 58 53 43 39 33 28 23 18 34 28 35 29 26 49 40 67 59 46 41 33 – 9.9 31 28 21 17 9.0 12 11 8.6 12 18 22 17 18 24 25 24 25
8.0 6.4 7.2 4.9 5.4 6.4 6.0 5.9 8.1 7.4 6.7 5.4 5.1 4.2 4.6 3.6 4.1 4.2 6.6 5.4 6.0 5.9 7.1 8.1 7.4 6.3 6.0 5.4 9.4 11 11 11 8.9 8.3 9.7 8.1 8.3 8.1 8.8 8.3
12 12 13 14 15 7.6 8.5 4.5 4.6 4.0 4.0 4.0 3.6 3.6 4.3 4.6 3.9 3.9 4.1 4.7 4.0 4.1 5.5 5.2 5.0 5.8 5.6 5.8 5.5 5.9 6.1 5.9 5.9 5.8 5.0 4.2 4.0 3.4 3.1 2.8
1.5 3.2 4.3 4.3 3.2 8.5 8.6 4.5 4.5 4.3 4.1 4.0 3.0 2.9 3.1 3.1 2.8 5.6 2.5 8.6 9.4 10 9.6 9.0 9.2 8.6 2.2 2.1 – – – – – – – – – – – –
0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.9 0.0 – – – – – – – – – – – – – – – – 2.3 – 11 11 11 10 10 10 10 9.9 9.8 9.7 9.5 9.4
27 30 30 26 25 26 25 25 25 25 29 27 24 24 45 42 43 44 43 45 48 46 42 39 38 33 28 29 31 31 30 30 28 27 22 22 20 20 22 21
7.3 10 10 7.7 7.6 9.1 8.4 11 13 13 16 15 12 12 13 11 13 13 11 34 22 21 20 19 19 18 15 17 21 17 15 15 14 14 11 11 9.6 9.6 9.9 11
– – – – – – – – – 5.5 1.7 3.5 2.6 2.3 1.5 1.3 1.2 1.2 1.4 23 10 – 8.6 8.6 8.1 4.1 5.1 0.0 8.2 2.2 2.0 2.7 2.6 2.4 2.1 2.7 2.2 1.9 2.7 3.7
3.4 5.9 3.9 3.9 4.2 4.2 4.0 3.2 6.9 4.5 4.5 4.1 3.2 3.0 3.1 3.3 4.2 4.2 3.3 4.9 4.8 3.7 4.2 2.9 3.1 4.1 5.2 5.9 3.9 4.5 4.9 3.3 2.6 2.9 1.9 1.5 1.5 2.0 3.4 3.2
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – 1.3 – – – 21 21 21 21 21 – 14 13 12 10 9.0 7.6 6.1 4.7 3.3 8.3 8.3 8.3 8.4 8.5 8.6 8.6 8.7 8.8 8.2 7.2
56 53 51 44 41 33 27 17 13 27 20 30 24 20 22 16 42 34 26 18 11 2.5 -4.8 20 16 14 13 9.4 22 21 21 23 29 33 32 30 37 37 36 35
-209 -214 -219 -226 -231 -240 -247 -258 -263 -272 -281 -291 -299 -307 -315 -321 -329 -337 -345 -354 -361 -370 -377 -382 -386 -389 -391 -394 -396 -397 -399 -399 -397 -398 -399 -401 -402 -403 -405 -406
0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.6 0.6 0.6 0.6 0.7 0.7 0.9 0.9 0.9 94 0.9 0.9 1.1 1.2 1.8 18 2.8 2.9 2.9 3.2 3.2 3.3 3.4 3.4 3.6 3.9 3.9 4.0

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?